Zydus Lifesciences – Sector: Pharmaceuticals Breakout Trigger:

gained momentum after USFDA approval for 4 new drugs and breakthrough results in their NASH and oncology drug pipeline. Long-Term Opportunity: Zydus is building a robust pipeline in specialty drugs and biosimilars with export-driven growth. Learning Point: Focus on pharma companies innovating in high-margin segments and getting global regulatory clearances.